Research Article

Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy

Table 2

Basic information of HGD active ingredients.

SignMol IDMolecule nameOB%DLSource

AMOL000392Formononetin69.670.21Huangqi and Gegen
GG1MOL000358Beta-Sitosterol36.910.75Gegen
GG2MOL0029593′-Methoxydaidzein48.570.24Gegen
GG3MOL003629Daidzein-4,7-diglucoside47.270.67Gegen
GG4MOL012297Puerarin24.030.69Gegen
HQ1MOL000211Mairin55.380.78Huangqi
HQ2MOL000239Jaranol50.830.29Huangqi
HQ3MOL000296Hederagenin36.910.75Huangqi
HQ4MOL000033(3 S,8 S,9 S,10 R,13R,14 S,17R)-10,13-Dimethyl-17-[(2R,5 S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol36.230.78Huangqi
HQ5MOL000354Isorhamnetin49.60.31Huangqi
HQ6MOL0003713,9-di-O-Methylnissolin53.740.48Huangqi
HQ7MOL0003787-O-Methylisomucronulatol74.690.3Huangqi
HQ8MOL0003799,10-Dimethoxypterocarpan-3-O-β-D-glucoside36.740.92Huangqi
HQ9MOL000380(6aR,11aR)-9,10-Dimethoxy-6a,11a-dihydro-6h-benzofurano[3,2-c]chromen-3-ol64.260.42Huangqi
HQ10MOL000387Bifendate31.10.67Huangqi
HQ11MOL000417Calycosin47.750.24Huangqi
HQ12MOL000422Kaempferol41.880.24Huangqi
HQ13MOL000433FA68.960.71Huangqi
HQ14MOL000438(3R)-3-(2-Hydroxy-3,4-dimethoxyphenyl) chroman-7-ol67.670.26Huangqi
HQ15MOL000439Isomucronulatol-7,2′-di-O-glucosiole49.280.62Huangqi
HQ16MOL0004421,7-Dihydroxy-3,9-dimethoxy pterocarpene39.050.48Huangqi
HQ17MOL000098Quercetin46.430.28Huangqi
HQ18-Astragalus polysaccharide--Huangqi
HQ19MOL000407Astragaloside IV22.500.15Huangqi

Notes: the predicted targets of MOL000374 and MOL000398 cannot be corrected, so they are not included in the statistical data. Abbreviations. OB: Oral bioavailability. DL: Drug-likeness.